Schilit SLP, Morton CC. 3C-PCR: a novel proximity ligation-based approach to phase chromosomal rearrangement breakpoints with distal allelic variants. Hum Genet. 2018;137(1):55-62. doi:10.1007/s00439-017-1853-0
Dardaei L, Wang HQ, Singh M, et al. SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors. Nat Med. 2018;24(4):512-517. doi:10.1038/nm.4497
Hoek KS. Exploring melanoma’s massively parallel universe. Pigment Cell Melanoma Res. 2010;23(3):306-7. doi:10.1111/j.1755-148X.2010.00691.x
Williams LJS, Tabbaa DG, Li N, et al. Paired-end sequencing of Fosmid libraries by Illumina. Genome Res. 2012;22(11):2241-9. doi:10.1101/gr.138925.112
Dulak AM, Stojanov P, Peng S, et al. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet. 2013;45(5):478-86. doi:10.1038/ng.2591
Vaishnavi A, Capelletti M, Le AT, et al. Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer. Nat Med. 2013;19(11):1469-72. doi:10.1038/nm.3352
Chmielecki J, Meyerson M. DNA sequencing of cancer: what have we learned?. Annu Rev Med. 2014;65:63-79. doi:10.1146/annurev-med-060712-200152
Zhang CZ, Leibowitz ML, Pellman D. Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangements. Genes Dev. 2013;27(23):2513-30. doi:10.1101/gad.229559.113
Choi PS, Meyerson M. Targeted genomic rearrangements using CRISPR/Cas technology. Nat Commun. 2014;5:3728. doi:10.1038/ncomms4728
Crompton BD, Stewart C, Taylor-Weiner A, et al. The genomic landscape of pediatric Ewing sarcoma. Cancer Discov. 2014;4(11):1326-41. doi:10.1158/2159-8290.CD-13-1037